Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


Articles published in Urology

Retrieve available abstracts of 166 articles:
HTML format



Single Articles


    February 2024
  1. FROEHNER M, Gorner M, Merkle L, Kopka K, et al
    (18)Fluorine prostate-specific membrane antigen 1007 positron emission tomography for high-risk prostate cancer.
    Urology. 2024 Feb 27:S0090-4295(24)00131-6. doi: 10.1016/j.urology.2024.
    PubMed    


  2. KHAN HM
    Editorial Commentary on Improving Racial Disparities in Prostate Cancer.
    Urology. 2024 Feb 21:S0090-4295(24)00095-5. doi: 10.1016/j.urology.2024.
    PubMed    


  3. MANDEL AL, Simhal RK, Shah YB, Wang KR, et al
    Racial disparities in diagnosis and treatment of depression Associated with androgen deprivation therapy for prostate cancer.
    Urology. 2024 Feb 21:S0090-4295(24)00094-3. doi: 10.1016/j.urology.2024.
    PubMed     Abstract available


  4. PASSARELLI R, Srivastava A
    Editorial Comment: Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
    Urology. 2024 Feb 20:S0090-4295(24)00091-8. doi: 10.1016/j.urology.2024.
    PubMed    


  5. HUNG M, Ross A, Li EV, Pavlovich CP, et al
    Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
    Urology. 2024 Feb 20:S0090-4295(24)00093-1. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  6. HUNG M, Hu JC
    Author Response: Prostate Cancer Detection Rate of Transperineal Prostate Biopsy: Cognitive Versus Software Fusion, A Multicenter Analysis.
    Urology. 2024 Feb 7:S0090-4295(24)00003-7. doi: 10.1016/j.urology.2024.
    PubMed    


    January 2024
  7. LANGBEIN BJ, Berk B, Bay C, Tuncali K, et al
    A Phase II Prospective Blinded Trial of MRI and In-Bore Biopsy in Active Surveillance for Prostate Cancer.
    Urology. 2024 Jan 11:S0090-4295(23)01122-6. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  8. GARCIA ROJO E, Garcia Gomez B, Sopena Sutil R, Vallejo Arzayus D, et al
    Comparison in Detection Rate of Clinically Significant Prostate Cancer Between Microultrasound-guided Prostate Biopsy (ExactVu) and Multiparametric Resonance Imaging-guided Prostate Biopsy (Koelis System).
    Urology. 2024;183:163-169.
    PubMed     Abstract available


  9. NITHIPALAN V, Holler T, Schuler N, Shepard L, et al
    Evaluation of Mixed Reality Technologies for Remote Feedback and Guidance During Transrectal Ultrasound Biopsy Simulation: A Prospective, Randomized, Crossover Study.
    Urology. 2024;183:25-31.
    PubMed     Abstract available


    December 2023
  10. GUPTA N, Zebib L, Wittmann D, Nelson CJ, et al
    Unmet sexual health resource needs and preferences for interventions to address these needs among female partners of patients with prostate cancer.
    Urology. 2023 Dec 29:S0090-4295(23)01109-3. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  11. DIRK K, Rourke K
    Health-Related Quality of Life in Patients with Urethral Stenosis after Radiation Treatment for Prostate Cancer.
    Urology. 2023 Dec 29:S0090-4295(23)01113-5. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  12. SAKAI A, Borza T, Antar A, Richmond E, et al
    Incidental prostate cancer diagnosis is common after holmium laser enucleation of the prostate.
    Urology. 2023 Dec 1:S0090-4295(23)01037-3. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  13. HIRST N, McBride KE, Thanigasalam R, Leslie S, et al
    Impact of Preoperative Mental Health on Surgical Outcomes Following Robotic-assisted Radical Prostatectomy.
    Urology. 2023;182:136-142.
    PubMed     Abstract available


  14. BUSBY D, Rich JM, Grauer R, Kaufmann B, et al
    Biopsy and Erectile Functional Outcomes of Partial Prostate Ablation: A Systematic Review and Meta-analysis of Prospective Studies.
    Urology. 2023;182:14-26.
    PubMed     Abstract available


  15. TAYLOR Z, Snow Z, Musallam S, Thomas B, et al
    Is Urethral Catheterization Necessary in Retzius-sparing Robot-assisted Radical Prostatectomy?
    Urology. 2023;182:133-135.
    PubMed     Abstract available


  16. MYRGA JM, Erpenbeck SP, Watts A, Stencel MG, et al
    Patient Reported Outcomes of Transperineal Prostate Biopsy With Tumescent Local Anesthesia.
    Urology. 2023;182:33-39.
    PubMed     Abstract available


  17. QUINN A, Klein R, Gochenaur L, Chun B, et al
    Transcorporal Artificial Urinary Sphincter Technique Video.
    Urology. 2023;182:e264-e265.
    PubMed     Abstract available


  18. SCHILLER E, Joshi P, El-Ali A, Brenseke W, et al
    In-utero Diagnosis of Prostatic Embryonal Rhabdomyosarcoma.
    Urology. 2023;182:e253-e256.
    PubMed     Abstract available


  19. HWANG A, Watson M, Talluri S, Okafor H, et al
    A Novel Perivesical Fat Rotational Flap as an Alternative to Omental Interposition in Challenging Urological Reconstruction.
    Urology. 2023;182:e262-e263.
    PubMed     Abstract available


    November 2023
  20. MYERS JB, Hernandez BS, McCormick B, Ramsay J, et al
    Comparison of Urinary Diversion in Patients with Prostatic Fistula to Those with Localized Radiation Injury after Radiotherapy for the Treatment of Prostate Cancer.
    Urology. 2023 Nov 29:S0090-4295(23)01029-4. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  21. STENSLAND KD, Caram ME, Herr DJ, Burns JA, et al
    National long-term survival estimates after radical prostatectomy for prostate cancer.
    Urology. 2023 Nov 9:S0090-4295(23)00987-1. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  22. GERETA S, Hung M, Alexanderani MK, Robinson BD, et al
    Evaluating the Learning Curve for In-office Freehand Cognitive Fusion Transperineal Prostate Biopsy.
    Urology. 2023;181:31-37.
    PubMed     Abstract available


  23. ARCEO-OLAIZ R, Smith EA, Stokes C, Eaton BR, et al
    Use of Perirectal Hyaluronic Acid Spacer Prior to Radiotherapy in a Pediatric Patient With Bladder Rhabdomyosarcoma: A Case Report.
    Urology. 2023;181:136-140.
    PubMed     Abstract available


  24. ENDERS JJ, Pinto PA, Xu S, Gomella P, et al
    A Novel Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy Technique Using Transperineal Ultrasound: An Initial Experience.
    Urology. 2023;181:76-83.
    PubMed     Abstract available


    October 2023
  25. HEBERT K, Bruno A, Matta R, Horns J, et al
    Impact of Prostate Cancer Related Genitourinary Radiation Injury on Mental Health Diagnosis and Treatment: Assessment of 55,425 Men.
    Urology. 2023 Oct 12:S0090-4295(23)00866-X. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  26. REZAEE ME, Gardner U, Alshak MN, Greco SC, et al
    Title: Effect of Transperineal versus Transrectal Prostate Biopsy on the Quality of Hydrogel Spacer Placement in Men prior to Radiation Therapy for Prostate Cancer.
    Urology. 2023 Oct 5:S0090-4295(23)00858-0. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


    September 2023
  27. MADHAVAN K, Jena R, Viswas MR, Kaushal D, et al
    Does Radical Local Treatment in oligometastatic Prostate Cancer improve Overall Survival- A systematic review and meta-analysis.
    Urology. 2023 Sep 27:S0090-4295(23)00833-6. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  28. BRAUN AE, Cowan JE, Hampson LA, Broering JM, et al
    Association between common urologic medications and onset of Alzheimer's disease and related dementias in men with prostate cancer managed by different primary treatment modalities.
    Urology. 2023 Sep 7:S0090-4295(23)00740-9. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  29. ODERDA M, Grimaldi S, Rovera G, Delsedime L, et al
    Robot-assisted PSMA-radioguided surgery to assess surgical margins and nodal metastases in prostate cancer patients: report on three cases using an intraoperative PET-CT specimen imager.
    Urology. 2023 Sep 3:S0090-4295(23)00730-6. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  30. XU AJ, Panken EJ, Gonzales-Alabastro CD, Zhang H, et al
    Urologists and Lesbian, Gay, Bisexual, Transgender, or Queer Patients: A Survey-based Study of the Practice Patterns, Attitudes, and Knowledge Base of Urologists Toward Their Lesbian, Gay, Bisexual, Transgender, or Queer Patients.
    Urology. 2023;179:71-79.
    PubMed     Abstract available


    August 2023
  31. AMBINDER D, Lubarsky R, Barnett J, Choudhury M, et al
    Author Reply to the Editorial Comment on Prostate Cancer: Under-representation of African American Men in Research Studies Used in the Latest NCCN Guidelines.
    Urology. 2023 Aug 27:S0090-4295(23)00629-5. doi: 10.1016/j.urology.2023.
    PubMed    


  32. IBILIBOR C
    Urology Editorial Comment for "Prostate Cancer: Under-representation of African American Men in Research Studies Used in the Latest NCCN Guidelines".
    Urology. 2023 Aug 27:S0090-4295(23)00628-3. doi: 10.1016/j.urology.2023.
    PubMed    


  33. BHANJI Y, Mamawala M, de la Calle CM, Landis P, et al
    Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) MRI Scoring to Predict Clinical Outcomes in Active Surveillance for Grade Group 1 Prostate Cancer.
    Urology. 2023 Aug 1:S0090-4295(23)00658-1. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  34. RAMOS-CARPINTEYRO R, Ferguson EL, Chavali JS, Geskin A, et al
    Single-port Transvesical Robot-assisted Radical Prostatectomy: The Surgical Learning Curve of the First 100 Cases.
    Urology. 2023;178:76-82.
    PubMed     Abstract available


    July 2023
  35. PAULA DOMINO M, Vertosick EA, Vickers AJ, Eastham JA, et al
    The association between low preoperative serum testosterone and post radical prostatectomy urinary function.
    Urology. 2023 Jul 27:S0090-4295(23)00654-4. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  36. LUBARSKY R, Ambinder D, Barnett J, Choudhury M, et al
    Prostate Cancer: Under-representation of African American men in research studies used in the latest NCCN guidelines.
    Urology. 2023 Jul 19:S0090-4295(23)00599-X. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  37. COSKUN B, Ocakoglu G, Yetemen M, Kaygisiz O, et al
    CAN CHATGPT, AN ARTIFICIAL INTELLIGENCE LANGUAGE MODEL, PROVIDE ACCURATE AND HIGH-QUALITY PATIENT INFORMATION ON PROSTATE CANCER?
    Urology. 2023 Jul 3:S0090-4295(23)00570-8. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  38. DHIR A, Ellimoottil CS, Qi J, Zhu A, et al
    Intra-practice Urologist-level Variation in Targeted Fusion Biopsy Outcomes.
    Urology. 2023;177:122-127.
    PubMed     Abstract available


  39. MICHAEL ZD, Kotamarti S, Deivasigamani S, Seguier D, et al
    A Comprehensive Assessment of the Utility of Transperineal Template Prostate Mapping Biopsy: A 13-year Experience.
    Urology. 2023;177:115-121.
    PubMed     Abstract available


  40. VALLI J, Haapiainen H, Murtola TJ, Huhtala H, et al
    Visual Analogue Scale and Expanded Prostate Cancer Index Composite-26 in the Evaluation of Urinary Continence Recovery After Three-Dimensional Laparoscopic Radical Prostatectomy, a Single-Center Prospective Registered Study.
    Urology. 2023;177:103-108.
    PubMed     Abstract available


  41. CRISOSTOMO-WYNNE T, Lee K, Speir R
    Robot-assisted Laparoscopic Prostatectomy After SpaceOAR Placement.
    Urology. 2023;177:228-229.
    PubMed     Abstract available


  42. DERIGS F, Kowalewski KF, Hartung FO, Waldbillig F, et al
    A Matched-pair Analysis Comparing Systematic Prostate Biopsy by Conventional Transrectal Ultrasound-guidance Versus Software-based Predefined 3D-Guidance.
    Urology. 2023;177:128-133.
    PubMed     Abstract available


    June 2023
  43. BENIDIR T, Lone Z, Wood A, Abdallah N, et al
    Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSA.
    Urology. 2023;176:115-120.
    PubMed     Abstract available


  44. FEIERTAG N, Tawfik MM, Loloi J, Patel RD, et al
    Should Men Eat More Plants? A Systematic Review of the Literature on the Effect of Plant-Forward Diets on Men's Health.
    Urology. 2023;176:7-15.
    PubMed     Abstract available


    May 2023
  45. HEBERT KJ, Matta R, Fendereski K, Horns JJ, et al
    Genitourinary Radiation Injury Following Prostate Cancer Treatment: Assessment of Cost and Health Care System Burden.
    Urology. 2023 May 30:S0090-4295(23)00457-0. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  46. LONERGAN PE, Baskin A, Greenberg SA, Mohamad O, et al
    The long-term incidence and quality of life outcomes associated with treatment-related toxicities of external beam radiotherapy for prostate cancer.
    Urology. 2023 May 25:S0090-4295(23)00444-2. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  47. GOLD SA, Goueli R, Mostardeiro TR, Carpinito GP, et al
    Optimal Prostate Cancer Diagnostic Pathways for Men with Prostatomegaly in the MRI Era.
    Urology. 2023 May 12:S0090-4295(23)00395-3. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  48. MAGANTY A, Hollenbeck BK, Kaufman SR, Oerline MK, et al
    Practice Competition and Treatment of Newly Diagnosed Prostate Cancer.
    Urology. 2023 May 3:S0090-4295(23)00383-7. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  49. MORRIS KE, Kotamarti S, Polascik TJ, Moul JW, et al
    Re-thinking How We Use Prostate Health Index for African American Men.
    Urology. 2023;175:144-150.
    PubMed     Abstract available


  50. WU S, Feldman AS, Kim MM, Lin SX, et al
    Gleason Grade Group Concordance between Systematic Template Combining Magnetic Resonance Imaging Fusion Targeted Biopsy and Radical Prostatectomy Specimens: A Comparison of Transperineal and Transrectal Approaches.
    Urology. 2023;175:151-156.
    PubMed     Abstract available


  51. SCOVELL JM, Stovsky M, Partin A, Lotan Y, et al
    IsoPSA Performance Characteristics are Unaffected by 5-Alpha Reductase Inhibitors or Alpha-Blockers: Results From the IsoPSA Validation Study.
    Urology. 2023;175:132-136.
    PubMed     Abstract available


  52. P AS, Patel H, Chandrashekar V, De Cruz A, et al
    Hematuria in an Adolescent Boy With Long-Standing Prostatic Utricle Cyst-An Ominous Sign.
    Urology. 2023;175:187-189.
    PubMed     Abstract available


    April 2023
  53. BULLER D, Sahl J, Staff I, Tortora J, et al
    Prostate Cancer Detection and Complications of Transperineal versus Transrectal MRI-Fusion Guided Prostate Biopsies.
    Urology. 2023 Apr 12:S0090-4295(23)00312-6. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  54. PETERSON DJ, Bhambhvani HP, Baird DRW, Li S, et al
    Prosteria - National Trends and Outcomes of More Frequent Than Guideline Recommended Prostate Specific Antigen Screening.
    Urology. 2023;174:92-98.
    PubMed     Abstract available


    March 2023
  55. PREMO H, Gordee A, Lee HJ, Scales CD Jr, et al
    Disparities in Prostate Cancer Screening for Transgender Women: An Analysis of the MarketScan Database.
    Urology. 2023 Mar 25:S0090-4295(23)00264-9. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  56. SADIGHIAN M, Hakam N, Amend G, Shaw NM, et al
    Radiation-induced fistulas in patients with prior pelvic radiotherapy for prostate cancer: a systematic review and meta-analysis.
    Urology. 2023 Mar 22:S0090-4295(23)00259-5. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  57. JOYCE DD, Tilburt JC, Pacyna JE, Cina K, et al
    The Impact of Within-Consultation and Pre-Consultation Decision Aids for Localized Prostate Cancer on Patient Knowledge: Results of a Patient-Level Randomized Trial.
    Urology. 2023 Mar 8:S0090-4295(23)00199-1. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  58. REZAEE ME, Li H, Pienta KJ
    An Enhancing Renal Mass in Metastatic Prostate Cancer.
    Urology. 2023 Mar 7:S0090-4295(23)00203-0. doi: 10.1016/j.urology.2023.
    PubMed    


    February 2023
  59. YANG L, Harper A, Imm KR, Grubb RL 3rd, et al
    Association between pre-surgical weight status and urinary and sexual function in prostate cancer patients treated by radical prostatectomy: a prospective cohort study.
    Urology. 2023 Feb 23:S0090-4295(23)00174-7. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  60. CRIBBS KA, Manning EF, Zhou J, Lahue BJ, et al
    Real-World Comparative Safety and Effectiveness of Irreversible Electroporation and High-Intensity Focused Ultrasound for Prostate Cancer Ablation.
    Urology. 2023 Feb 1:S0090-4295(23)00071-7. doi: 10.1016/j.urology.2023.
    PubMed     Abstract available


  61. HAAPIAINEN H, Valli J, Murtola T, Huhtala H, et al
    Visual Analogue Scale (VAS) in the Evaluation of Functional Outcomes After Three-dimensional Laparoscopic Prostatectomy.
    Urology. 2023;172:121-125.
    PubMed     Abstract available


    January 2023
  62. GANGWISH D, Zwaans BMM, Miriani P, Dejoie W, et al
    Prevalence and Causes of Discontinuation of Androgen Receptor Inhibitors in Advanced Prostate Cancer Patients and Analysis of Physician Management to Increase Duration of Therapy.
    Urology. 2023 Jan 2:S0090-4295(22)01099-8. doi: 10.1016/j.urology.2022.
    PubMed     Abstract available


  63. PRILLAMAN GE, Tuong M, Yeaman CT, Farhi J, et al
    Complex Foley Catheter Placement After Radical Prostatectomy.
    Urology. 2023;171:251.
    PubMed     Abstract available


  64. KRUGHOFF K, Livingston AJ, Inouye B, Peterson AC, et al
    Indications and Outcomes for Intermittent Catheterization following Bulbar AUS Cuff Placement.
    Urology. 2023;171:216-220.
    PubMed     Abstract available


  65. ABOU ZEINAB M, Beksac AT, Ferguson E, Kaviani A, et al
    Single-port Extraperitoneal and Transperitoneal Radical Prostatectomy: A Multi-Institutional Propensity-Score Matched Study.
    Urology. 2023;171:140-145.
    PubMed     Abstract available


  66. ZHAO CC, Rossi JK, Wysock JS
    Systematic Review and Meta-Analysis of Free-Hand and Fixed-Arm Spatial Tracking Methodologies in Software-Guided MRI-TRUS Fusion Prostate Biopsy Platforms.
    Urology. 2023;171:16-22.
    PubMed     Abstract available


  67. POZZI E, Ventimiglia E, Fallara G, Capogrosso P, et al
    Haemospermia in the Real- Life Setting: A New High-Risk Stratification.
    Urology. 2023;171:146-151.
    PubMed     Abstract available


  68. LIU HQ, Ding W, Tao LS, Shen XD, et al
    Catheterization Before Transperineal Ultrasound-guided Prostate Biopsy and the Risk of Urethrorrhagia.
    Urology. 2023;171:23-28.
    PubMed     Abstract available


  69. RAMOS F, Korets R, Fleishman A, Kaul S, et al
    Comparative Effectiveness of Magnetic Resonance Imaging-Ultrasound Fusion Versus In-bore Magnetic Resonance Imaging-targeted Prostate Biopsy.
    Urology. 2023;171:164-171.
    PubMed     Abstract available


  70. PARIKH KD, Declouette B, Chen M, Rao S, et al
    Evaluating the Downstream Revenues of a Self-Pay Bi-Parametric Prostate MRI Program.
    Urology. 2023;171:109-114.
    PubMed     Abstract available


    December 2022
  71. ANDOLFI C, Vickers AJ, Cooperberg MR, Carroll PR, et al
    Blood Prostate-specific Antigen by Volume of Benign, Gleason Pattern 3 and 4 Prostate Tissue.
    Urology. 2022;170:154-160.
    PubMed     Abstract available


    November 2022
  72. SIAPNO AED, Gaither TW, Tandel MD, Kwan L, et al
    Impact of Comprehensive Health Insurance on Quality of Life in Low-Income Hispanic Men with Prostate Cancer.
    Urology. 2022 Nov 15. pii: S0090-4295(22)00954.
    PubMed     Abstract available


  73. MANN RA, Kasabwala K, Buckley JC, Smith TG, et al
    The "Fragile" Urethra as a Predictor of Early Artificial Urinary Sphincter Erosion.
    Urology. 2022;169:233-236.
    PubMed     Abstract available


    October 2022
  74. KANABOLO D, True L, Vakar-Lopez F, Tretiakova M, et al
    Prostate-specific Antigen (PSA) Screening and a Lifesaving Cardiac Transplant.
    Urology. 2022;168:e1-e2.
    PubMed    


  75. MORRISON JC, Sax-Bolder A, Gershman B, Konety B, et al
    Geographic Variation of Infectious Complications Following Prostate Biopsy in The United States: Results From a Population-Based Cohort of Privately Insured Patients.
    Urology. 2022;168:27-34.
    PubMed     Abstract available


    September 2022
  76. CHOE S, Patel HD, Lanzotti N, Okabe Y, et al
    MRI vs Transrectal Ultrasound to Estimate Prostate Volume and PSAD: Impact on Prostate Cancer Detection.
    Urology. 2022 Sep 21. pii: S0090-4295(22)00806.
    PubMed     Abstract available


  77. IMBER BS, O'Dwyer E, Lobaugh S, McBride SM, et al
    Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation.
    Urology. 2022 Sep 14. pii: S0090-4295(22)00779.
    PubMed     Abstract available


  78. HUANG D, Yang X, Liu Y, Huang Z, et al
    Prostate Cancer presenting as a solitary sacral osteolytic metastasis mimicking chordoma on (18)F-FDG PET/CT.
    Urology. 2022 Sep 14. pii: S0090-4295(22)00798.
    PubMed    


  79. INOUYE BM, Krischak MK, Krughoff K, Boysen WR, et al
    Resection of Pubic Symphysis and Cystectomy Significantly Improves Short-Term Patient-Reported Physical Functioning Among Patients With Pubovesical Fistula and Pubic Bone Osteomyelitis.
    Urology. 2022;167:218-223.
    PubMed     Abstract available


  80. MOVASSAGHI M, Ahmed F, Patel H, Luk L, et al
    Association of Patient and Imaging-Related Factors With False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions.
    Urology. 2022;167:165-170.
    PubMed     Abstract available


    August 2022
  81. HARRINGTON SA, Fialk G, Raman JD
    RE: "Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach".
    Urology. 2022;166:297-298.
    PubMed    


    July 2022
  82. OKABE Y, Patel HD, Rac G, Gupta GN, et al
    Multifocality of Prostate Cancer and Candidacy for Focal Therapy Based on Magnetic Resonance Imaging.
    Urology. 2022 Jul 29. pii: S0090-4295(22)00631.
    PubMed     Abstract available


  83. NASSIRI N, Richardson S, Kuppermann D, Brisbane WG, et al
    Partial gland ablation of prostate cancer: Effects of Repeat Treatment.
    Urology. 2022 Jul 27. pii: S0090-4295(22)00617.
    PubMed     Abstract available


  84. CALLEJAS MF, Klein EA, Truong M, Thomas L, et al
    Detection of clinically significant index prostate cancer using micro-ultrasound: correlation with radical prostatectomy.
    Urology. 2022 Jul 14. pii: S0090-4295(22)00592.
    PubMed     Abstract available


  85. DE BARROS HA, Remmers S, Luiting HB, van Leenders GJLH, et al
    Predictive value of Cribriform and Intraductal Carcinoma for the Nomogram-Based Selection of Prostate Cancer Patients for Pelvic Lymph Node Dissection.
    Urology. 2022 Jul 5. pii: S0090-4295(22)00537.
    PubMed     Abstract available


  86. WERNEBURG GT, Adler A, Zhang A, Mukherjee SD, et al
    Transperineal Prostate Biopsy is Associated With Lower Tissue Core Pathogen Burden Relative to Transrectal Biopsy: Mechanistic Underpinnings for Lower Infection Risk in the Transperineal Approach.
    Urology. 2022;165:1-8.
    PubMed     Abstract available


  87. HARRISON R, Stifelman M, Billah M, Zaifman J, et al
    Propensity-Score Matched Analysis Between Extraperitoneal Single Port and Intraperitoneal Multiport Radical Prostatectomy: A Single-Institutional Experience.
    Urology. 2022;165:198-205.
    PubMed     Abstract available


  88. LANE GI, Qi J, Dupati A, Ferrante S, et al
    Assessing the Impact of Decision Aid Use on Post Prostatectomy Patient Reported Outcomes.
    Urology. 2022;165:187-192.
    PubMed     Abstract available


  89. SLOPNICK EA, Bagby C, Mahran A, Nagel C, et al
    Skene's Gland Malignancy: A Case Report and Systematic Review.
    Urology. 2022;165:36-43.
    PubMed     Abstract available


    June 2022
  90. DELANEY RK, Sisco-Taylor BL, Wang X, Scherr K, et al
    Two Specialists, Two Recommendations: Discordance between Urologists' & Radiation Oncologists' Prostate Cancer Treatment Recommendations.
    Urology. 2022 Jun 26. pii: S0090-4295(22)00512.
    PubMed     Abstract available


  91. BENIDIR T, Hofmann M, Lone Z, Nguyen JK, et al
    Elevated IsoPSA Selects for Clinically Significant Prostate Cancer Without a Preference for Any Particular Adverse Histopathologic or Radiographic Feature.
    Urology. 2022 Jun 6. pii: S0090-4295(22)00449.
    PubMed     Abstract available


  92. JEONG SH, Werneburg GT, Abouassaly R, Wood H, et al
    Acquired and Congenital Spinal Cord Injury is Associated With Lower Likelihood of Prostate Specific Antigen Screening.
    Urology. 2022;164:178-183.
    PubMed     Abstract available


  93. CHIU PKF, Ahmed HU, Rastinehad AR
    TRUS Biopsy vs Transperineal Biopsy for Suspicion of Prostate Cancer.
    Urology. 2022;164:18-20.
    PubMed    


  94. TOSOIAN JJ, Singhal U, Davenport MS, Wei JT, et al
    Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need.
    Urology. 2022;164:184-190.
    PubMed     Abstract available


    April 2022
  95. GOLDENTHAL SB, Reimers MA, Singhal U, Farha M, et al
    Prostate Cancer with Peritoneal Carcinomatosis: A robotic-assisted radical prostatectomy-based Case Series.
    Urology. 2022 Apr 23. pii: S0090-4295(22)00296.
    PubMed     Abstract available


    March 2022
  96. PINO MD, Abern MR, Moreira DM
    Prostate Cancer Disparities in Hispanics using the National Cancer Database.
    Urology. 2022 Mar 26. pii: S0090-4295(22)00256.
    PubMed     Abstract available


  97. LOWENTRITT B, Brown G, Pilon D, Ellis L, et al
    Real-World Prostate-Specific Antigen Response and Treatment Adherence of Apalutamide in Patients with Non-Metastatic Castration-Resistant Prostate Cancer.
    Urology. 2022 Mar 19. pii: S0090-4295(22)00245.
    PubMed     Abstract available


  98. NASRI J, Barthe F, Parekh S, Ratnani P, et al
    Nomogram predicting adverse pathology outcome on radical prostatectomy in low-risk prostate cancer men.
    Urology. 2022 Mar 6. pii: S0090-4295(22)00173.
    PubMed     Abstract available


  99. KUPERUS JM, Tobert CM, Semerjian AM, Qi J, et al
    Pelvic Lymph Node Dissection at Radical Prostatectomy for Intermediate Risk Prostate Cancer: Assessing Utility and Nodal Metastases Within a Statewide Quality Improvement Consortium.
    Urology. 2022 Mar 6. pii: S0090-4295(22)00166.
    PubMed     Abstract available


  100. BEARRICK EN, Findlay BL, Maciejko LA, Hebert KJ, et al
    Robotic Urethral Reconstruction Outcomes in Men With Posterior Urethral Stenosis.
    Urology. 2022;161:118-124.
    PubMed     Abstract available


    February 2022
  101. MASON MM, Nackeeran S, Lokeshwar SD, Blachman-Braun R, et al
    PSA Testing in Men Receiving Testosterone Therapy with History of Prostate Cancer: A Matched Analysis of a Large Multi-Institutional Research Network.
    Urology. 2022 Feb 25. pii: S0090-4295(22)00161.
    PubMed     Abstract available


  102. LIM M, Qureshi MM, Boyd G, Hirsch AE, et al
    Effect of Radiation Treatment at a High-Volume Center on Outcomes in Intermediate-Risk Prostate Cancer: An Analysis of the National Cancer Database.
    Urology. 2022 Feb 16. pii: S0090-4295(22)00144.
    PubMed     Abstract available


  103. HACKER EC, Maganty A, Pere MM, Rusilko PJ, et al
    Outcomes of Vesicourethral Anastomotic Stenosis and Bladder Neck Contracture with Direct Visual Internal Urethrotomy with Mitomycin-C After Prostate Cancer Treatment.
    Urology. 2022 Feb 12. pii: S0090-4295(22)00110.
    PubMed     Abstract available


  104. LAVI A, Yudkevich B, Pechansky S, Tzemach S, et al
    Author Reply.
    Urology. 2022;160:159.
    PubMed    


    January 2022
  105. VERSALLE D, Qi J, Noyes S, Moriarity A, et al
    Practice-level variation in the decision to biopsy PI-RADS 3 lesions in favorable-risk prostate cancer patients.
    Urology. 2022 Jan 23. pii: S0090-4295(22)00070.
    PubMed     Abstract available


  106. KOTAMARTI S, George A, Zhu A, Polascik TJ, et al
    Transrectal Ultrasound-Guided Biopsy Should Continue to Be a Standard of Care for The Detection of Prostate Cancer.
    Urology. 2022 Jan 14. pii: S0090-4295(22)00018.
    PubMed     Abstract available


  107. ROEBUCK E, Sha W, Lu C, Miller C, et al
    Racial and Socioeconomic Disparities in MRI-Fusion Biopsy Utilization to Assess for Prostate Cancer.
    Urology. 2022 Jan 4. pii: S0090-4295(21)01201.
    PubMed     Abstract available


  108. REDMOND EJ, Doiron RC, Rourke KF
    Development of New Comorbidities in Patients Awaiting Urinary Incontinence Surgery Following Radical Prostatectomy.
    Urology. 2022;159:235-240.
    PubMed     Abstract available


    December 2021
  109. NAKAI Y, Tanaka N, Asakawa I, Miyake M, et al
    Mirabegron reduces urinary frequency and improves overactive bladder symptoms at 3 months after (125)I-brachytherapy for prostate cancer: An open-labeled, randomized, non-placebo-controlled study.
    Urology. 2021 Dec 29. pii: S0090-4295(21)01183.
    PubMed     Abstract available


  110. WITTMANN D, Varlamos C, Rodriguez-Galano N, Day L, et al
    Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction with a Survivorship Program Embedded in Urologic-oncologic Care.
    Urology. 2021 Dec 8. pii: S0090-4295(21)01153.
    PubMed     Abstract available


  111. SABA P, Melnyk R, Holler T, Oppenheimer D, et al
    Comparison of Multi-Parametric MRI of the Prostate to 3D Prostate Computer Aided Designs and 3D-Printed Prostate Models for Pre-Operative Planning of Radical Prostatectomies: A Pilot Study.
    Urology. 2021;158:150-155.
    PubMed     Abstract available


    November 2021
  112. LAVI A, Yudkevich B, Pechansky S, Tzemach S, et al
    Implications of a Novel Biopsy Downloading System on Prostate Cancer Detection Rate, Surveillance and Focal Therapy - A Prospective Study.
    Urology. 2021 Nov 12. pii: S0090-4295(21)01039.
    PubMed     Abstract available


  113. VERTOSICK EA, Zappala S, Punnen S, Hugosson J, et al
    Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume.
    Urology. 2021;157:102-106.
    PubMed     Abstract available


  114. LORENZ U, Samaseika Y, Balsmeyer U, Neumann N, et al
    Multicystic Prostate Tumor.
    Urology. 2021;157:41.
    PubMed    


    October 2021
  115. SEIDEN B, Weng S, Sun N, Gordon D, et al
    NCCN Risk Reclassification in Black men with low and intermediate risk Prostate Cancer after genomic testing.
    Urology. 2021 Oct 21. pii: S0090-4295(21)00979.
    PubMed     Abstract available


  116. SPITZNAGEL T, Hardenberg JV, Schmid FA, Rupp NJ, et al
    Salvage Robotic-assisted Laparoscopic Radical Prostatectomy Following Focal High-Intensity Focused Ultrasound for ISUP 2/3 Cancer.
    Urology. 2021;156:147-153.
    PubMed     Abstract available


    September 2021
  117. ESDAILLE AR, Ibilibor C, Ii AH, Palmer NR, et al
    Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer.
    Urology. 2021 Sep 25. pii: S0090-4295(21)00893.
    PubMed     Abstract available


  118. BERTOLO R, Garisto J, Bove P, Mottrie A, et al
    Perioperative Outcomes Between Single-Port and "Multi-Port" Robotic Assisted Radical Prostatectomy: Where do we stand?
    Urology. 2021;155:138-143.
    PubMed     Abstract available


  119. DE LA CALLE CM, Shee K, Chu CE, Cowan JE, et al
    Association of Age With Risk of Adverse Pathological Findings in Men Undergoing Delayed Radical Prostatectomy Following Active Surveillance.
    Urology. 2021;155:91-95.
    PubMed     Abstract available


  120. PRESS BH, Khajir G, Ghabili K, Leung C, et al
    Utility of PSA Density in Predicting Upgraded Gleason Score in Men on Active Surveillance With Negative MRI.
    Urology. 2021;155:96-100.
    PubMed     Abstract available


  121. SAYYID RK, Klotz L, Benton JZ, Lodh A, et al
    Influence of Sociodemographic Factors on Definitive Intervention Among Low-risk Active Surveillance Patients.
    Urology. 2021;155:117-123.
    PubMed     Abstract available


  122. CHECCUCCI E, Piramide F, Amparore D, De Cillis S, et al
    Beyond the Learning Curve of Prostate MRI/TRUS Target Fusion Biopsy after More than 1000 Procedures.
    Urology. 2021;155:39-45.
    PubMed     Abstract available


  123. CRICCO-LIZZA E, Wilcox Vanden Berg RN, Laviana A, Pantuck M, et al
    Comparative Effectiveness and Tolerability of Transperineal MRI-Targeted Prostate Biopsy under Local versus Sedation.
    Urology. 2021;155:33-38.
    PubMed     Abstract available


  124. LEE AY, Chen K, Law YM, Ho HS, et al
    Robot-assisted Magnetic Resonance Imaging-ultrasound Fusion Transperineal Targeted Biopsy.
    Urology. 2021;155:46.
    PubMed     Abstract available


  125. WEI G, Papa N, Kelly B, Bolton D, et al
    Trends in the Uptake of Diagnostic Multi-Parametric MRI of the Prostate With Federal Funding: Australia Population Data.
    Urology. 2021;155:9-11.
    PubMed    


  126. BRIGGS LG, Kim M, Gusev A, Rumpf F, et al
    Evaluation of In-Office MRI/US Fusion Transperineal Prostate Biopsy via Free-hand Device during Routine Clinical Practice.
    Urology. 2021;155:26-32.
    PubMed     Abstract available


  127. LEVY A, Fleishman A, Jackson M, Waisman A, et al
    Using Preoperative Pelvic Floor Assessment to Predict Early Return of Continence after Robotic Radical Prostatectomy.
    Urology. 2021;155:160-164.
    PubMed     Abstract available


  128. ALTOK M, Chapin BF, Matin SF, Achim MF, et al
    Therapeutic Consequences of Omitting a Pelvic Lymph Node Dissection at Radical Prostatectomy when Grade and/or Stage Increase.
    Urology. 2021;155:144-151.
    PubMed     Abstract available


  129. MEHTA A, Kim WC, Aswad KG, Brunckhorst O, et al
    Erectile Function Post Prostate Biopsy: A Systematic Review and Meta-analysis.
    Urology. 2021;155:1-8.
    PubMed     Abstract available


    August 2021
  130. BREE KK, Hensley PJ, Pettaway CA
    Germline Mutations in African American Men with Prostate Cancer: Incidence, Implications and Diagnostic Disparities.
    Urology. 2021 Aug 25. pii: S0090-4295(21)00796.
    PubMed     Abstract available


  131. POSIELSKI N, Frankel J, Kuo HC, Ho O, et al
    IMPACT OF AGE AND RACE ON HEALTH-RELATED QUALITY OF LIFE OUTCOMES IN PATIENTS UNDERGOING RADICAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER.
    Urology. 2021 Aug 21. pii: S0090-4295(21)00783.
    PubMed     Abstract available


  132. VINCE RA JR, Jamieson S, Mahal B, Iii WU, et al
    Examining the Racial Disparities in Prostate Cancer.
    Urology. 2021 Aug 18. pii: S0090-4295(21)00772.
    PubMed     Abstract available


  133. BERG RNWV, Basourakos SP, Shoag J, Scherr D, et al
    Prostate Cancer Screening for Gay Men in the United States.
    Urology. 2021 Aug 8. pii: S0090-4295(21)00734.
    PubMed     Abstract available


  134. JAMIESON SC, Mallory CW, Jivanji DR, Perez A, et al
    THE ROLE OF HEALTH LITERACY IN PROSTATE CANCER SCREENING.
    Urology. 2021 Aug 7. pii: S0090-4295(21)00735.
    PubMed     Abstract available


  135. LEWICKI P, Arenas-Gallo C, Basourakos SP, Awamlh BAHA, et al
    Re: Dudith Pierre-Victor, Howard L. Parnes, Gerald L. Andriole, et al. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening. Urology 2021 Jun 26;S0090-4295(21)00539-2.
    Urology. 2021 Aug 3. pii: S0090-4295(21)00722.
    PubMed    


  136. BORGES DA PONTE C, Leitao TP, Miranda M, Polido J, et al
    Prostate Ewing Sarcoma/PNET: A case of long survival in a highly aggressive malignancy.
    Urology. 2021;154:e11-e12.
    PubMed     Abstract available


    July 2021
  137. DEROUEN MC, Yang J, Jain J, Weden MM, et al
    Disparities in prostate cancer survival according to neighborhood archetypes, a population-based study.
    Urology. 2021 Jul 22. pii: S0090-4295(21)00674.
    PubMed     Abstract available


  138. PATEL HD, Doshi CP, Koehne EL, Hart S, et al
    African American Men have Increased Risk of Prostate Cancer Detection despite Similar Rates of Anterior Prostatic Lesions and PI-RADS Grade on Multiparametric Magnetic Resonance Imaging.
    Urology. 2021 Jul 21. pii: S0090-4295(21)00678.
    PubMed     Abstract available


  139. SESSINE MS, Das S, Park B, Salami SS, et al
    Initial Findings from a High Genetic Risk Prostate Cancer Clinic.
    Urology. 2021 Jul 16. pii: S0090-4295(21)00647.
    PubMed     Abstract available


  140. GAYLIS F, Nasseri R, Salmasi A, Anderson C, et al
    Implementing Continuous Quality Improvement in an Integrated Community Urology Practice: Lessons Learned.
    Urology. 2021;153:139-146.
    PubMed     Abstract available


  141. WARNER JN, Gallegos MA
    Letter to the Editor RE: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021;153:359-360.
    PubMed    


  142. SHAH N, Ioffe V
    Re: Letter to the Editor: Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis. Deepansh Dalela et al. (Urology 2021;148:1-3).
    Urology. 2021;153:360-361.
    PubMed    


    June 2021
  143. PIERRE-VICTOR D, Parnes HL, Andriole GL, Pinsky PF, et al
    Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening.
    Urology. 2021 Jun 26. pii: S0090-4295(21)00539.
    PubMed     Abstract available


  144. CHANDRASEKAR T, Bowler N, Schneider A, Goldberg H, et al
    Outcomes of Active Surveillance for Men with Intermediate Risk Prostate Cancer, A Population-Based Analysis.
    Urology. 2021 Jun 26. pii: S0090-4295(21)00560.
    PubMed     Abstract available


  145. KAWA SM, Stroomberg HV, Larsen SB, Helgstrand JT, et al
    Detection of clinically significant prostate cancer by systematic TRUS-biopsies in a population-based setting over a 20 year period.
    Urology. 2021 Jun 22. pii: S0090-4295(21)00538.
    PubMed     Abstract available


  146. CAMPBELL RA, Li J, Malone L, Levy DA, et al
    Correlative Analysis of Vitamin D and Omega-3 Fatty Acid Intake in Men on Active Surveillance for Prostate Cancer.
    Urology. 2021 Jun 15. pii: S0090-4295(21)00525.
    PubMed     Abstract available


  147. SOERENSEN SJC, Thomas IC, Schmidt B, Daskivich T, et al
    Reply to the Editorial Comment on: Using an Automated Electronic Health Record Score To Estimate Life Expectancy In Men Diagnosed With Prostate Cancer In The Veterans Health Administration. Urology. 2021.
    Urology. 2021 Jun 14. pii: S0090-4295(21)00488.
    PubMed     Abstract available


  148. CHAO B, Lepor H
    5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer.
    Urology. 2021 Jun 3. pii: S0090-4295(21)00460.
    PubMed     Abstract available


    May 2021
  149. HESTERBERG AB, Gordetsky JB, Hurley PJ
    Cribriform Prostate Cancer: Clinical Pathologic and Molecular Considerations.
    Urology. 2021 May 28. pii: S0090-4295(21)00442.
    PubMed     Abstract available


  150. KING MC, Sardi A, Velez-Mejia C, Sittig M, et al
    Novel Case of Isolated Peritoneal Carcinomatosis from Metastatic Prostate Cancer Carrying a Pathogenic BRCA Mutation Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Urology. 2021 May 25. pii: S0090-4295(21)00435.
    PubMed     Abstract available


  151. ARMSTRONG N, Bahl A, Pinkawa M, Ryder S, et al
    SpaceOAR Hydrogel spacer for reducing radiation toxicity during radiotherapy for prostate cancer. A systematic review.
    Urology. 2021 May 22. pii: S0090-4295(21)00421.
    PubMed     Abstract available


  152. SCHUBBE ME, Gellhaus PT, Tobert CM, Mott SL, et al
    Knowledge and Attitudes Regarding Surgical Castration in Men Receiving Androgen Deprivation Therapy for Metastatic Prostate Cancer and Their Relationship to Health-Related Quality of Life.
    Urology. 2021 May 7. pii: S0090-4295(21)00368.
    PubMed     Abstract available


  153. KF R
    Re: Multi-Institutional Outcomes and Associations after Excision and Primary Anastomosis for Radiotherapy-Associated Bulbomembranous Urethral Stenoses Following Prostate Cancer Treatment.
    Urology. 2021 May 1. pii: S0090-4295(21)00355.
    PubMed    


    April 2021
  154. PAUDEL R, Ferrante S, Qi J, Dunn RL, et al
    Patient preferences and treatment decisions for prostate cancer: Results from a statewide urological quality improvement collaborative.
    Urology. 2021 Apr 29. pii: S0090-4295(21)00350.
    PubMed     Abstract available


  155. NORRIS JM, Ball R, Freeman A, Ghei M, et al
    Patient Perspectives and Understanding of MRI-Directed Prostate Cancer Diagnosis.
    Urology. 2021 Apr 3. pii: S0090-4295(21)00301.
    PubMed    


    March 2021
  156. MADI R, Sayyid RK, Hiffa A, Thomas E, et al
    Early Experience with Salvage Retzius-sparing Robotic-assisted Radical Prostatectomy: Oncologic and Functional Outcomes.
    Urology. 2021;149:117-121.
    PubMed     Abstract available


  157. LINDSAY J, Uribe S, Moschonas D, Pavlakis P, et al
    Patient Satisfaction and Regret After Robot-assisted Radical Prostatectomy: A Decision Regret Analysis.
    Urology. 2021;149:122-128.
    PubMed     Abstract available


  158. NAITO H, Kato T, Ishikawa R, Tanaka K, et al
    The Impact of Histopathological Features of Prostate Cancerous Lesions on Multiparametric Magnetic Resonance Imaging Findings using PI-RADS Version 2.
    Urology. 2021;149:174-180.
    PubMed     Abstract available


  159. WONG D, Rincon J, Henning G, Smith Z, et al
    Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates.
    Urology. 2021;149:129-132.
    PubMed     Abstract available


  160. GUERRIOS-RIVERA L, Howard LE, Klaassen Z, Terris MK, et al
    Do Hispanic Men Have Worse Outcomes After Radical Prostatectomy? Results From SEARCH.
    Urology. 2021;149:181-186.
    PubMed     Abstract available


    February 2021
  161. SAPIENZA LG, Ning MS, Carvalho EF, Spratt D, et al
    Efficacy and Incontinence Rates After Urethroplasty for Radiation-Induced Urethral Stenosis: A Systematic Review and Meta-Analysis.
    Urology. 2021 Feb 22. pii: S0090-4295(21)00190.
    PubMed     Abstract available


  162. DALELA D, Sood A, Keeley J, Rogers C, et al
    Generalizability of Prostate-Specific Antigen (PSA) Screening Trials in a "Real World" Setting: A Nationwide Survey Analysis.
    Urology. 2021;148:1-3.
    PubMed    


  163. KUBOTA M, Matsuoka T, Yamasaki T, Kokubun H, et al
    Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy.
    Urology. 2021;148:151-158.
    PubMed     Abstract available


  164. ETAFY MH, Katz JE, Gonzalgo MR, Garcia Lopez EA, et al
    Holmium Laser Enucleation of Prostate Within 6 Weeks of Transrectal Ultrasound Guided Prostate Biopsy is Safe and Effective.
    Urology. 2021;148:88-92.
    PubMed     Abstract available


    January 2021
  165. HUANG MM, Patel HD, Wainger JJ, Su ZT, et al
    Comparison of Perioperative and Pathologic Outcomes Between Single-port and Standard Robot-assisted Radical Prostatectomy: An Analysis of a High-volume Center and the Pooled World Experience.
    Urology. 2021;147:223-229.
    PubMed     Abstract available


    January 2020
  166. PATEL MS, Halpern JA, Desai AS, Keeter MK, et al
    Success of Prostate and Testicular Cancer Awareness Campaigns Compared to Breast Cancer Awareness Month According to Internet Search Volumes: A Google Trends Analysis.
    Urology. 2020 Jan 27. pii: S0090-4295(20)30081.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.